Figure S1 from Combination Therapy with NHS-muIL12 and Avelumab (Anti-Pd-l1) Enhances Antitumor Efficacy in Preclinical Cancer ModelsChunxiao Xu, Yanping Zhang,P. Alexander Rolfe,Vivian M. Hernández,Wilson Guzman,Giorgio Kradjian,Bo Marelli,Guozhong Qin,Jin Qi, Hong Wang,Huakui Yu,Robert Tighe,Kin-Ming Lo,Jessie M. English,Laszlo Radvanyi,Yan Lancrossref(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要